Patent · US Active

Pleuromutilin derivatives for the treatment of diseases mediated by microbes

US8153689B2 · kind B2 · utility

2Cited by

0References

5Claims

0Family size

Assignee

NABRIVA THERAPEUTICS GMBH · AT

Inventors

Rosemarie Mang · Wien, AT
Werner Heilmayer · Staprijk, AT
Rudolf Badegruber · Wien, AT
Dirk Strickmann · Wien, AT
Rodger Novak · Wien, AT
Mathias Ferencic · Wien, AT
Atchyuta Rama Chandra Murty Bulusu · Perchtoldsdorf, AT

Key dates

Filing date	Oct 4, 2011
Grant date	Apr 10, 2012
Priority date	—
Expiry date	Oct 4, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/99
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are pleuromutilin derivatives of formula (I)and their use in the treatment of diseases mediated by microbes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.